Lifeline Cell Technology, LLC – Trademark Portfolio
Entity Type: 16
Lifeline Cell Technology, LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include LIFELINE, VASCULIFE, and LIFELINE CELL TECHNOLOGY. The owner is based in Frederick, MD.
Frederick, MD 21701
Showing of trademarks Trademarks
Trademark Classifications
Lifeline Cell Technology, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Lifeline Cell Technology, LLC have?
Lifeline Cell Technology, LLC has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned, 2 cancelled.
What trademark classes does Lifeline Cell Technology, LLC file in?
Lifeline Cell Technology, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Lifeline Cell Technology, LLC's most well-known trademarks?
Lifeline Cell Technology, LLC's registered trademark portfolio includes well-known marks such as LIFELINE, VASCULIFE, and LIFELINE CELL TECHNOLOGY. These are among 4 currently registered trademarks in the portfolio.
What is Lifeline Cell Technology, LLC's trademark registration success rate?
Lifeline Cell Technology, LLC has a 50% trademark registration rate, with 4 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.